• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

珊瑚硫酸酯骨替代物

Coralline-sulfate bone substitutes.

作者信息

Khavari F, Bajpai P K

机构信息

Department of Biology, University of Dayton, OH 45469-2320.

出版信息

Biomed Sci Instrum. 1993;29:65-9.

PMID:8329637
Abstract

Filling irregular defects caused by trauma or surgery with particulate bone substitutes usually results in migration of the particles from the wound. Coralline blocks have been used successfully to replace diseased bone. Immobilizing coralline particles should be useful in repairing bone defects. Coralline particles of < 45 microns were blended with < 45 microns particles of calcium or zinc sulfate (10%, 20% or 30%). Five gram blocks (20 x 10 mm) of the mixture were pressed at 800 pounds force. Blocks of coral-calcium sulfate were heated at 1000 degrees C and coral-zinc sulfate at 500 degrees C for two hours. The heated blocks were cooled, crushed and sized to < 45 microns particles. Distilled water (200-240 microliters) was added to 210 mg of coralline or coralline-sulfates. A circular rubber mold (10 x 4 mm) was filled with the paste and allowed to harden. Hardness was tested by applying pressure to the tablets at four minute intervals. Consistency equivalent to hardened plaster of Paris was recorded as maximum hardness. Coralline alone did not harden on addition of water. Mixing sulfates with coralline immobilized the particles to maximum hardness within 60 minutes on addition of water. Variation in the amounts of sulfate added (10%-30%) to coralline did not affect the hardening characteristics of the composite.

摘要

用颗粒状骨替代物填充由创伤或手术引起的不规则缺损通常会导致颗粒从伤口处迁移。珊瑚块已成功用于替代病变骨骼。固定珊瑚颗粒在修复骨缺损方面应该是有用的。将小于45微米的珊瑚颗粒与小于45微米的硫酸钙或硫酸锌颗粒(10%、20%或30%)混合。将5克该混合物块(20×10毫米)在800磅力下压制。珊瑚 - 硫酸钙块在1000℃加热,珊瑚 - 硫酸锌块在500℃加热两小时。加热后的块冷却、粉碎并筛选成小于45微米的颗粒。向210毫克珊瑚或珊瑚 - 硫酸盐中加入200 - 240微升蒸馏水。将糊状物填充到圆形橡胶模具(10×4毫米)中并使其硬化。每隔四分钟对片剂施加压力来测试硬度。相当于熟石膏硬化后的稠度被记录为最大硬度。仅加入水时,珊瑚本身不会硬化。将硫酸盐与珊瑚混合后,加水后60分钟内颗粒固定至最大硬度。向珊瑚中添加的硫酸盐量(10% - 30%)的变化不影响复合材料的硬化特性。

相似文献

1
Coralline-sulfate bone substitutes.珊瑚硫酸酯骨替代物
Biomed Sci Instrum. 1993;29:65-9.
2
Zinc sulfate calcium phosphate (ZSCAP) composite for repairing traumatized bone.用于修复创伤性骨的硫酸锌磷酸钙(ZSCAP)复合材料。
Biomed Sci Instrum. 1992;28:183-8.
3
In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model.在兔胫骨缺损模型中对可吸收骨移植替代物的体内评估。
Biomaterials. 2004 Sep;25(20):5037-44. doi: 10.1016/j.biomaterials.2004.02.014.
4
The research of degradability of a novel biodegradable coralline hydroxyapatite after implanted into rabbit.新型可生物降解珊瑚羟基磷灰石植入兔体内后的降解性研究。
J Biomed Mater Res A. 2009 Mar 1;88(3):741-6. doi: 10.1002/jbm.a.31424.
5
A ferric calcium phosphorous oxide (FECAP) ceramic for rebuilding bone.
Biomed Sci Instrum. 1993;29:59-64.
6
[Repairing the defect of benign bone tumor with the coralline hydroxyapatite].[应用珊瑚羟基磷灰石修复良性骨肿瘤缺损]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 May;33(5):421-4.
7
Hydroxyapatite/calcium carbonate (HA/CC) vs. plaster of Paris: a histomorphometric and radiographic study in a rabbit tibial defect model.羟基磷灰石/碳酸钙(HA/CC)与巴黎石膏的比较:兔胫骨缺损模型的组织形态计量学和放射学研究
Calcif Tissue Int. 2002 Aug;71(2):172-8. doi: 10.1007/s00223-001-1087-x. Epub 2002 Jun 5.
8
Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants.在种植体周围骨缺损治疗中使用颗粒状牙本质-熟石膏组合材料并联合/不联合富血小板血浆。
Int J Oral Maxillofac Implants. 2002 Jan-Feb;17(1):86-94.
9
Bioactive calcium pyrophosphate glasses and glass-ceramics.生物活性焦磷酸钙玻璃和玻璃陶瓷。
Acta Biomater. 2005 Jan;1(1):55-64. doi: 10.1016/j.actbio.2004.08.001.
10
The bioactive atelocollagen/hydroxyapatite composite as bone filler histological study on rats.
Polim Med. 1997;27(1-2):39-45.